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Key points
 The gut hormone called glucagon-like peptide 1 (GLP-1) is a strong moderator of energy
homeostasis and communication between the peripheral organs and the brain.
 GLP-1 signalling occurs in the brain; using a newly developed genetic reporter line of mice, we
have discovered GLP-synthesizing cells in the olfactory bulb.
 GLP-1 increases the firing frequency of neurons (mitral cells) that encode olfactory information
by decreasing activity of voltage-dependent K channels (Kv1.3).
 ModifyingGLP-1 levels, either therapeutically or following the ingestion of food, could alter the
excitability of neurons in the olfactory bulb in a nutrition or energy state-dependent manner
to influence olfactory detection or metabolic sensing.
 The results of the present study uncover a new function for an olfactory bulb neuron (deep
short axon cells, Cajal cells) that could be capable of modifying mitral cell activity through the
release of GLP-1. This might be of relevance for the action of GLP-1mimetics nowwidely used
in the treatment of diabetes.
Abstract The olfactory system is intricately linked with the endocrine system where it may serve
as a detector of the internal metabolic state or energy homeostasis in addition to its classical
function as a sensor of external olfactory information. The recent development of transgenic
mGLU-yellow fluorescent protein mice that express a genetic reporter under the control of
the preproglucagon reporter suggested the presence of the gut hormone, glucagon-like peptide
(GLP-1), in deep short axon cells (Cajal cells) of the olfactory bulb and its neuromodulatory
effect on mitral cell (MC) first-order neurons. A MC target for the peptide was determined
using GLP-1 receptor binding assays, immunocytochemistry for the receptor and injection of
fluorescence-labelled GLP-1 analogue exendin-4. Using patch clamp recording of olfactory bulb
slices in the whole-cell configuration, we report that GLP-1 and its stable analogue exendin-4
increase the action potential firing frequency of MCs by decreasing the interburst interval rather
than modifying the action potential shape, train length or interspike interval. GLP-1 decreases
Kv1.3 channel contribution to outward currents in voltage clamp recordings as determined
by pharmacological blockade of Kv1.3 or utilizing mice with Kv1.3 gene-targeted deletion as
a negative control. Because fluctuations in GLP-1 concentrations monitored by the olfactory
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bulb can modify the firing frequency of MCs, olfactory coding could change depending upon
nutritional or physiological state. As a regulator of neuronal activity, GLP-1 or its analogue may
comprise a new metabolic factor with a potential therapeutic target in the olfactory bulb (i.e. via
intranasal delivery) for controlling an imbalance in energy homeostasis.
(Resubmitted 15 January 2016; accepted after revision 25 February 2016; first published online 2 March 2016)
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Introduction
Energy homeostasis is dependent upon neuronal and
hormonal communication between the peripheral organs
and the brain. Glucagon-like peptide 1 (GLP-1) is an
incretin hormone secreted from intestinal L-cells
following a meal (Holst, 2007). Peripheral GLP-1 exerts
strong effects on the control of energy metabolism
by regulating glycaemia, stimulating glucose-dependent
insulin secretion and proinsulin gene expression, and
inhibiting glucagon release and gastric emptying (Holst,
2007). In the central nervous system, cell bodies of GLP-1
producing neurons have been identified in the caudal
nucleus of the solitary tract and intermediate reticular
nucleus (Jin et al. 1988; Larsen et al. 1997; Merchenthaler
et al. 1999; Hisadome et al. 2010; Trapp & Richards,
2013). These neurons send axons to several areas in the
brain, including the paraventricular nucleus, the dorso-
medial hypothalamus and the nucleus accumbens (Larsen
et al. 1997; Tauchi et al. 2008; Llewellyn-Smith et al.
2011). Direct central infusion of GLP-1 has been shown to
inhibit food and water intake and to reduce blood glucose
(Tang-Christensen et al. 1996; Kinzig et al. 2002; Dossat
et al. 2011).
The receptor for GLP-1 (GLP-1R) is a seven trans-
membrane domain, G-protein coupled receptor that is
expressed in a wide variety of tissues, including the
hypothalamus and the nucleus accumbens, where GLP-1
has been demonstrated to play a role in the control
of food intake (Dossat et al. 2011). Ligand binding
of the peptide to GLP-1R triggers activation of the
Gαs protein, which leads to the production of cAMP
through the activation of the enzyme adenylate cyclase.
Elevation of cAMP concentration in the cell increases
protein kinase A activity, which results in the inhibition
of potassium channels, KATP, Kv2.1 and Kv1.5, as well
as the auxiliary Kvβ2 protein subunit (Gromada et al.
1998a; Gromada et al. 1998b; MacDonald et al. 2003;
Kim et al. 2012; Kim et al. 2013) by phosphorylation or
acetylation. This results in a reduction of the Kv current
amplitude or reduced Kv surface trafficking, either of
whichwould cause increased depolarization. In pancreatic
β-cells, GLP-1R activation also induces an elevation of
intracellular Ca2+ concentrations through modification
of L-type Ca2+ channels and the oscillation of Ca2+
through Ca2+-induced Ca2+ release from intracellular
stores (Holst, 2007).
Most studies investigating the second messengers
involved in GLP-1 signalling have been performed
in pancreatic β-cells where GLP-1 stimulates glucose-
dependent insulin release. GLP-1, however, has also
been shown to increase membrane excitability of
nodose ganglion neurons by decreasing the potassium
conductance of both inactivating and delayed-rectifier
potassium currents (Gaisano et al. 2010). Nodose neurons
areno longermodulatedby thepeptide followingblockade
of K+ currents with the relatively non-selective antagonist,
4-AP.
Because the olfactory system is intricately linked with
the endocrine system, it may not only serve as an
external sensor of olfactory information, but also as an
internal sensor of metabolic state or energy homeo-
stasis (Palouzier-Paulignan et al. 2012). It has been
reported previously that hormonal and metabolic factors
modulate the excitability of olfactory sensory neurons,
as well as mitral cells (MCs) representing the first-order
neurons in the olfactory bulb (OB) (Fadool et al. 2000;
Fadool et al. 2011; Aime et al. 2012; Soria-Gomez et al.
2014). Initial electrophysiological studies exploringneuro-
endocrinemodulation focusedupon the hormone insulin,
which has the highest binding affinity and receptor density
reported for the OB compared to all other brain regions
(Hill et al. 1986; Banks et al. 1999). Other factors, such
as orexins, have been shown to modulate MC firing
frequency (Apelbaum et al. 2005; Hardy et al. 2005).
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 000.0 GLP-1 modulation in the olfactory bulb 3
Orexins originate from neurons in the lateral hypo-
thalamic area that send centrifugal projections to the OB
(Gascuel et al. 2012). Prud’homme et al. (2009) have
demonstrated that the release of the orexigenic peptide
within the OB is highly dependent upon nutritional status
(fasted vs. satiated). Recently, our group demonstrated
that other metabolic factors, including glucose itself,
modulate the firing frequency ofMCs (Tucker et al. 2013),
suggesting that there is a glucose-sensitive population
of MCs detecting changes in glucose homeostasis. In
MCs, glucose and insulin use a mechanism that involves
changes in excitability driven by a voltage-dependent
potassium channel, Kv1.3, as demonstrated by the lack
of response to these metabolic factors in MCs from mice
with gene-targeted deletion of Kv1.3 (Kv1.3−/−) (Fadool
et al. 2011; Tucker et al. 2013).
Hormonal regulation occurring within the olfactory
system is hypothesized to modulate olfactory sensitivity
and the hedonic representation of odours following
changes in nutritional state. For example, the endo-
canabinoid system has recently been shown to be involved
in the modulation of olfactory sensitivity and food intake
through activation of CB1 receptors in the olfactory
system(Soria-Gomez et al.2014).Moreover, dysregulation
of energy metabolism affects the olfactory system.
Rodent models of genetic- or diet-induced obesity have
demonstrated both anatomical and functional changes
in the olfactory system (Badonnel et al. 2012; Tucker
et al. 2012; Thiebaud et al. 2014). Such changes have
an impact on olfactory-linked food behaviours or food
intake.
Although a single previous study has used in situ
hybridization to characterize the expression of pre-
proglucagon (PPG) and the GLP-1 receptor in the
olfactory system (Merchenthaler et al. 1999), the physio-
logical functions of the GLP-1 pathway, as well as
protein expression and localization, remain completely
unexplored. The recent development of transgenic
mGLU-yellow fluorescent protein (YFP) mice, expressing
the yellow fluorescent protein, Venus, under the control of
the glucagon promoter (Reimann et al. 2008), allowed us
to confirmthepresenceofGLP-1producingneurons in the
OB.FollowingGLP-1 receptorbinding assays and labelling
experiments in mice with a genetic reporter for MCs, we
conjectured that MCs were a target for the endogenous
peptide. Accordingly, we performed a biophysical analysis
of GLP-1 modulation on these first-order neurons. Using
the whole-cell configuration of the patch clamp in OB
slices, we determined themechanismof actionofGLP-1 or
its stable analogue exendin-4 (Ex4) on MCs. Fluctuations
in GLP-1 concentrations were able to modify the intrinsic
firing frequency of MCs and alter the olfactory coding in
response to a changedphysiological state, suchas following
a meal or after fasting.
Methods
Ethical approval
All experiments described in the present study were
approved by the Florida State University Institutional
Animal Care and Use Committee (IACUC) under
protocols #1124 and #1427, and were conducted in
accordance with the American Veterinary Medicine
Association (AVMA), the National Institutes of Health,
and the UK Home Office Regulations under the Animals
Scientific Procedures Act (ASPA) 1986. In preparation
for OB slice electrophysiology, mice were anaesthetized
with isoflurane (Aerrane; Baxter, Deerfield, IL, USA)
using the IACUC-approved drop method and then were
killed by decapitation (AVMA Guidelines on Euthanasia,
June 2007). These procedures are contained in the ASPA
Schedule 1 (Wolfenshon & Lloyd, 2003) for the species,
stage of development, and size of ourmice (see below). All
authors understood the ethical principles that The Journal
of Physiology operates under and the work complied with
the animal ethics checklist reported by Grundy (2015).
Animal care and mouse lines
All mice were housed at the Florida State University,
Imperial College London, or University College London
vivaria in accordance with the institutional requirements
for animal care. All mice used in the present study (Mus
musculus, C57BL/6 background strain; Jax Laboratories,
Bar Harbor, ME, USA) were maintained under a standard
12:12 h light/dark cycle andwere allowed ad libitum access
to 5001 Purina Chow (Purina, Richmond, VA, USA) and
water. Mice of both sexes were aged from postnatal day
21 to 35 at the time of the experiment unless otherwise
noted, and had a body weight in the range 8.4–20.0 g
(mean ± SD: 15.9 ± 2.5 g). A total of 62 wild-type
(WT), 12 Kv1.3−/−, three olfactory marker protein-green
fluorescent protein (OMP-GFP), nine PPG-YFP, three
GLP-1R-tdRFP, three Thy1-YFP and three GLP-1R−/−
mice were used in the present study. Kv1.3−/− mice were
produced previously by excision of the Kv1.3 promoter
region and one-third of the 5′ coding region (Koni et al.
2003; Xu et al. 2003) and were a generous gift from Drs
Leonard Kaczmarek and Richard Flavel (Yale University,
New Haven, CT, USA). Mice with an olfactory marker
protein GFP transgene (OMP-GFP) (Potter et al. 2001)
were used to identify all mature olfactory sensory neurons
and were a gift from Dr Peter Mombaerts (Max Plank
Institute, Frankfort,Germany).PPG-YFPmice, expressing
the YFP variant Venus (Nagai et al. 2002) under the
control of the mouse PPG promotor (mGLU-124 line)
(Reimann et al. 2008), were used to identify proglucagon
expressing neurons. Briefly, mice were generated using
mouse bacterial artificial chromosomes using the RedEt
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technique (Zhang et al. 2000). Pronuclear injection of
bacterial artificial chromosome constructs containing
the Venus sequence in place of the coding region of
PPG resulted in the generation of founder mice with
the transgene (mGLU-124 line). GLP-1R Cre mice that
express Cre-recombinase under the GLP-1R promoter
were generated as described previously (Richards et al.
2014). These mice were crossed with ROSA26-tdRFP
reporter strains (Luche et al. 2007) to enable fluorescence
detection of cells expressing GLP-1R by cytosolic tdRFP
expression. Thy1-YFPmice were used to identifyMCs and
were a gift from Dr Guoping Feng (MIT Broad Institute,
Boston, MA, USA) (Feng et al. 2000). GLP-1R−/− mice
were a generous gift from Dr Julio E. Ayala (Diabetes
and Obesity Research Centre, Orlando, FL, USA) (Ayala
et al. 2009).
Solutions, reagents and antisera
Margatoxin (MGTX) was purchased from Sigma-Aldrich
(St Louis, MO, USA) and used to selectively block the
vestibule of the Kv1.3 channel (Knaus et al. 1995).
TTX was purchased from Ascent Scientific (Princeton,
NJ, USA) or Abcam Biochemicals (Cambridge, MA,
USA) to block voltage-gated sodium channels. GLP-1,
glucagon-like peptide 1 (7-36)-lys (biotin) (Ref
46-1-65) and GLP-1-(7-36) amide were purchased from
American Peptide Company (Sunnyvale, CA, USA).
Phosphate-buffered saline (PBS) was made as described
previously (Tucker & Fadool, 2002). Slice intracellular
pipette solution contained (in mM): 135 potassium
gluconate, 10 KCl, 10 Hepes, 10 MgCl2, 0.4 NaGTP
and 2 NaATP (pH 7.3; 280–285 mOsm). Artificial
cerebral spinal fluid (aCSF) contained (in mM): 119 NaCl,
26.2 NaHCO3, 1 NaH2PO4, 2.5 KCl, 1.3 MgCl2, 2.5 CaCl2
and 22 D-glucose (pH 7.3; 310–315 mOsm). In experi-
ments where the external concentration of potassium was
adjusted to alter the calculated reversal potential for K+,
KCl was modified to 2.5 or 8.5 mM. Sucrose-modified
aCSF was used for sectioning and contained (in mM):
83 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 3.3 MgCl2,
0.5 CaCl2, 72 sucrose and 22 D-glucose (pH 7.3;
315 mOsm) (De Saint Jan & Westbrook, 2007). All salts
and sugars were purchased from Sigma-Aldrich or Fisher
Scientific (Pittsburgh, PA, USA).
The GLP-1R antibody (dilution 1:3000) was a
generous gift from Dr Joel Habener (Harvard Catalyst,
Cambridge, MA, USA) and Dr Scott Heller (Hagedorn
Research Institute, Denmark) and was generated against
the N-terminal epitope (CQHRYERWKQVTESLSVT)
in rabbits (Heller et al. 1996). Chicken anti-GFP
was purchased from Abcam Biochemicals (dilution
1:50,000, catalogue number ab13970) and was designed
to recognize the enhanced form of GFP, and all of the
fluorescent proteins made by Aequorea victoria, including
YFP. The insulin receptor (IR) kinase antibody was
a mouse monoclonal directed against the β subunit
(dilution 1:1000, Clone CT-3; catalogue number 05-1104;
Millipore, Billerica, MA, USA). Host-specific secondary
antibodies were purchased from Jackson Immuno-
Research (West Grove, PA, USA) and used in accordance
with the manufacturer’s instructions. GLP1-R expressing
cells from GLP-1R transgenic line were detected using
a far red polyclonal antibody, DsRed (dilution 1:1000,
catalogue number 632496; Clontech, Palo Alto, CA, USA)
using protocols described previously (Cork et al. 2015).
Immunocytochemistry
YFP-immunoreactivity in GLP-1 neurons was visua-
lized in PPG-YFPmice as described previously (Llewellyn-
Smith et al. 2011; Llewellyn-Smith et al. 2013). Briefly,
a total of five mice aged 12–16 weeks and weighing
between 25 and 35 g were perfused intracardially
with 4% paraformaldehyde (PFA). The head was sub-
sequently postfixed in 4% PFA/PBS overnight and
decalcified for 3–5 days in 0.3 M EDTA and prepared for
cryosectioning (30 μm) as described in Thiebaud et al.
(2014). YFP-immunoreactivity was confirmed in parallel
experiments using an antibody to GFP (see antibodies).
Here, an immunoperoxidase protocol in conjunction
with a metal-intensified diaminobenzidine reaction was
used to optimally visualize the morphology of GLP-1
neurons (Llewellyn-Smith et al. 2011). A total of fourmice
for the immunoperioxidase studies were perfused with
4% PFA/PBS. Brains with attached OBs were removed
and post-fixed for 3 days at room temperature in the
same fixative. OBs were infiltrated with sucrose and
cryosectioned (30 μm). A BH-2 microscope (Olympus,
Tokyo, Japan) equipped with a SPOT Insight Model 18.2
firewire colour camera and SPOT, version 4.6 (Diagnostic
Instruments, Inc., Sterling Heights, MI, USA) was used to
capture images.
To localize GLP-1R by immunocytochemical
approaches, a total of three adult mice were used. Mice
were intracardially perfused with 4% paraformaldehyde
in PBS (PFA/PBS). The OBs were postfixed overnight in
4% PFA, decalcified for 3–5 days in 0.3 M EDTA, and
then prepared for cryosectioning (12 μm) as described in
Thiebaud et al. (2014). Prepared OB frozen sections were
air-dried for 30 min, fixed in 1% PFA/PBS, washed three
times in PBS and then incubated for 30 min in 3% bovine
serum albumin/PBS to block non-specific binding. For
use of the IR kinase antibody, it was also necessary
to perform a demasking step by boiling sections (i.e.
microwave) in 10 mM citrate buffer (pH 6.0) for 4 min for
epitope retrieval prior to the blocking step in accordance
with the manufacturer’s instructions. After the blocking
step, the tissue sections were incubated overnight with
the primary antiserum (dilution in PBS + 3% BSA) at
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the same time as protecting from light and maintaining
sections at 4°C. The immunofluorescence signal was
detected after a 2 h incubation with host-specific Cy3 or
Cy2 secondary antisera diluted in PBS (dilution 1:200;
Jackson ImmunoResearch). After three washes in PBS,
nuclei were additionally stained by incubating slides
for 5 min in 4′,6-diamidino-2-phenylindole (DAPI)
nuclear stain diluted in PBS (dilution 1:15,000; Life
Technologies, Carlsbad, CA, USA), washing again in
PBS and coverslipping with Fluoromount G (Southern
Biotechnology, Birmingham, AL, USA) to prevent photo-
bleaching. OB sections were examined by brightfield and
fluorescence using an Axiovert S100 inverted microscope
(Carl Zeiss Microimaging, Thornwood, NY, USA). Digital
images were captured with an Axiocam digital camera
and AxioVision, version 4.8 (Carl Zeiss Microimaging).
GLP-1 binding assay
The GLP-1-biotin binding assay was performed on three
WT mice as adapted from Cowley et al. 2003. Briefly,
150 μm vibratome sections of OB were obtained in
ice-cold, sucrose-modified aCSF. The oxygenated (95%
O2/5% CO2) sections recovered for 1 h in an inter-
face chamber in normal aCSF (Fadool et al. 2011) and
were then incubated with either 1 μM GLP-1-biotin
conjugate or a mix of 1 μM GLP-1-biotin conjugate
with 2 μM of ‘cold’ GLP-1 (unconjugated) for 20 min
at +4ºC. The sections were subsequently fixed with 4%
PFA/PBS for 10 min, washed in PBS and incubated in
1:200 Cy3-streptavidin (Life Technologies) for 30 min.
The sections were stained with DAPI nuclear stain
(dilution 1:15,000), washed in PBS, and then mounted
and visualized as described above.
In another experiment, Thy-1-YFP mice that express
YFP in MCs or GLP-1R−/− mice received a S.C. injection
(120 nmol kg−1) of fluorescence-labelled Ex4 [Cys(HiLyte
Fluor647 C2 maleimide)]-exendin-4 (Ref AS-63714;
AnaSpec, Fremont, CA, USA). The animals were trans-
cardially perfused with 4% PFA 4 h after injection and the
OBs were processed and cryosectioned at a thickness of
12 μM as described previously (Thiebaud et al. 2014).
OB slice electrophysiology
A total of 79 mice were used for 197 patch clamp
electrophysiology recordings from OB slices as described
previously (Fadool et al. 2011). Following isoflurane
anaesthesia, the mice were killed by decapitation. The
OBs were rapidly exposed by removing the dorsal and
lateral portions of the cranium between the cribriform
plate and the lambda suture as described previously
(Nickell et al. 1996). After removing the dura, the OBs
(when still attached to the forebrain) were quickly
removed, glued to a sectioning block with Superglue
(Lowe’s Home Improvement, Tallahassee, FL, USA) and
submerged in oxygenated, ice-cold, sucrose-modified
aCSF to prepare the tissue for sectioning (De Saint Jan
&Westbrook, 2007). Coronal sections (275 μm) were cut
in oxygenated, ice-cold, sucrose-modified aCSF using a
Series 1000 Vibratome (Leica, Wetzlar, Germany). The
sections were allowed to recover in an interface chamber
(Krimer & Goldman-Rakic, 1997) with oxygenated,
sucrose-modified aCSF at 33°C for 30 min and then
maintained at room temperature in oxygenated normal
aCSF until needed (De Saint Jan & Westbrook, 2007;
Fadool et al. 2011). Neuronal slices were visualized at 10×
and 40× using an Axioskop 2FS Plus microscope (Carl
Zeiss Microimaging) equipped with infrared detection
capabilities (CCD100; Dage-MTI, Michigan City, IN,
USA).
Membrane voltage and current properties were
generated using pCLAMP, version 9 or 10, in conjunction
with an Axopatch 200B amplifier (Axon Instruments,
Foster City, CA, USA). The analogue signal was filtered
at 2 kHz and minimally digitally sampled every 100 μs.
Electrodes were fabricated from borosilicate glass
(#1405002; Hilgenberg GmbH, Malsfeld, Germany) to a
diameter of 2 μm to yield pipette resistances ranging
from 4 to 7 M. Positive pressure was retained when
navigating through the OB laminae until a high resistance
seal (1.5–10G) was obtained on a positionally-identified
MC in the slice (Fadool et al. 2011). The morphology
and biophysical properties of the neurons were used to
distinguish MCs from tufted cells. In addition, thy1-YFP
transgenic mice comprised a good tool to secondarily
confirm cell identity as in the study by Fadool et al. 2011
(Fig. 1). The whole-cell configuration was established by
applying gentle suction to the lumen of the pipette at
the same time as monitoring resistance. Each MC was
first sampled for adequate resting potential (less than
–55 mV) and proper series resistance (less than 40 M)
prior to initiating a series of current clamp recordings.
Only current clamp recordings with a sustained resting
membrane potential (RMP) of at least –50 mV or an
input resistance (Rin) of at least 150 M were accepted.
During recordings, the membrane potential (Em) was
adjusted to –65 mV by injecting a few pA of current so
that data could be statistically evaluated from the same
potential across cells.
For current clamp recordings, the perithreshold current
level was determined by incrementally injecting 1 s long,
25 pA steps of current every 10 s, starting at –50 pA.
Following the determination of spike threshold, cells were
then stimulated with a long, perithreshold current step
(typically ranging from 25 to 100 pA) of 5000 ms at
an interpulse interval of 10 s to acquire spike frequency
data before and after peptide or drug application. In
general, recordings were acquired for a minimum of
30 min following application of peptide. Latency to first
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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spike, spike event frequency (calculated throughout step
depolarization), interburst interval (calculated between
spike cluster), interspike interval (ISI) (calculated within a
spike cluster) and action potential (AP) cluster lengthwere
measured as described previously (Balu et al. 2004; Fadool
et al. 2011; Mast & Fadool, 2012). A cluster was defined
as three or more consecutive spikes with an ISI of 100 ms
or less as established by Balu et al. (2004). Because MC
firing is intrinsically intermittent and is characterized by
variable spike clusters, classical means of computing spike
timing variability, such as peristimulus time histograms,
were less suitable for the behaviour of these neurons and
therefore alternative means of spike analysis were applied
as described previously (Balu et al. 2004).
For voltage clamp recordings, voltage-activated
outward currents were elicited using a 400 ms voltage
stimulation protocol with a holding potential (Vh) of
–80 mV and command potential (Vc) steps from –100
to +40 mV in 10 mV increments. Interpulse intervals
were taken at 45 s to prevent cumulative inactivation of
the Kv1.3 current that is expressed in MCs (Marom et al.
1993; Fadool & Levitan, 1998).
Statistical analysis
All electrophysiological data were analysed using
pClamp, version 10 (Clampfit 10.2; Axon Instruments),
Prism, version 5 (GraphPad Software, Inc., La Jolla,
CA, USA) and Igor Pro, version 6.12A (Wave-
Metrics Inc., Portland, OR, USA) with the plug-in
NeuroMatic, version 2 (written by Jason Rothman;
http://www.neuromatic.thinkrandom.com). The pipette
capacitance was electrically compensated through the
capacitance neutralization circuit of the Axopatch 200B
amplifier. Similarly, series resistance compensation was
used to electrically reduce the effect of pipette resistance.
Voltage clamp traces were subtracted linearly for leakage
conductance.Restingmembranepotentialswere corrected
for a –14 mV junction potential offset.
For voltage clamp experiments, the peak transient
current was defined as the greatest current evoked after
voltage activation. Current–voltage relationships were
plotted by normalizing the peak transient current to either
cell capacitance or to the maximum evoked current at
+40 mV. The family of current–voltage relations was
compared (via Prism) using a repeated measures two-way
ANOVA (and a Bonferoni post hoc test) with peptide and
voltage step as factors. For current clamp experiments,
change in the AP frequency, ISI or interburst interval were
plotted as the mean percentage change compared to the
control condition prior to bath application of the peptide.
Baseline, treatment and washout values were calculated
from the mean of 10 consecutives traces generated
from a 5 s duration current injection. For statistical
analyses, Prism was used to perform the Friedman
test (non-parametric alternative for repeated measures
ANOVA) followed by Bonferoni’s post hoc comparison
test. All data are reported as the mean ± SEM. Different
letters denote statistically different mean values with the
corresponding P value as specified. Statistical difference
was defined at the 95% confidence interval (or α 0.05),
unless otherwise specified.
Results
Localization of PPG-neurons in the OB
Immunocytochemical localization of GLP-1 peptide can
yield precarious results as a result of non-specific labelling
by commercially-available antibodies. We avoided this
issue by using transgenic PPG-YFP mice and took
advantage of the YFP expression that occurs throughout
GCL
MCL
EPL
GLM
100μm 100μm 50μm
A B
Figure 1. Preproglucagon positive (PPG+) short axon cells are visualized in the OB
A, photomicrograph of a representative coronal section of the mouse OB of a PPG-YFP mouse demonstrating
native YFP labelling of dSAC within the GCL. Also visible in the section are other neurolamina, MCL, EPL and
the glomerular cell layer (GLM). Note the position of the soma in the upper portion of the GCL and the axon
projections into the MCL and EPL. B, same as in (A) but labelled using a metal-intensified diaminobenzidine
reaction in conjunction with an anti-GFP antibody to optimally visualize the short axon morphology. Inset: higher
magnification of the boxed area is shown on the right. Note that the YFP-immunoreactive cells are stellate with
dendrites containing spine-like structures or a varicose appearance.
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the cytoplasm of these neurons, including their terminals
(Hisadome et al. 2010). Immunohistochemical detection
using an anti-GFP antiserum was found to significantly
enhance the native fluorescence signal of the YFP
as described previously (Llewellyn-Smith et al. 2011;
Llewellyn-Smith et al. 2013). YFP fluorescence revealed
a large population of PPG-neurons located in the granule
cell layer (GCL) of the OB (Fig. 1A). The somata
were positioned in the upper portion of the GCL with
axonal arbors reaching into the mitral cell layer (MCL)
and external plexiform layer (EPL). In the GCL, the
refined peroxidase labelling strategy revealed that the
PPG-neurons had stellate dendrites covered with many
spines (Fig. 1B) that are characteristic of deep short-axon
cells (dSACs), also named Cajal cells as described pre-
viously (Ramo´n y Cajal S., 1911; Price & Powell, 1970;
Eyre et al. 2008; Eyre et al. 2009; Nagayama et al.
2014). At higher magnification (Fig. 1B), we could
discern that the size of the soma was slightly larger
(10.20 ± 0.21 μm, n = 73 from three mice) compared
to that reported for granule cells (Woolf et al. 1991; Eyre
et al. 2009).
GLP-1R is expressed in the MCL and the GCL
Following the identification of the PPG neurons in the
OB, we next investigated the presence of the potential
target receptor, or GLP-1R, by immunolocalization.
We used a home-made antisera (generously provided
by Scott Heller) to reveal immunoreactivity mainly in
the MCL, as well as in sparse cells within the GCL
(Fig. 2A). Using a recently developed transgenic mouse
model expressing Cre-recombinase under the control of
the GLP-1R promoter with a ROSA26-EYFP reporter
(GLP-1R-Cre mice; Richards et al. 2014), we confirmed
GLP-1R expression in the same MCL and GCL regions
(data not shown). These results are in accordance with
a previous study reporting GLP-1R mRNA in the MCL
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Figure 2. GLP-1R is expressed in the granular
cell and MCLs of the mouse OB
A, left: photomicrographs of representative coronal
sections of the OB of an OMP-GFP mouse carrying
a transgene for olfactory marker protein, OMP. The
six-panel composite demonstrates fluorescence
labelling using an antibody directed against GLP-1R
(left; red) with no signal in the GLM, defined
labelling in the MCL and scattered labelling in the
GCL. Merged image on the right using
double-colour fluorescence strategy to visualize the
GFP (green) and receptor (red) overlay. DAPI nuclear
stain (blue). Entire OB for perspective shown on the
right. B, RT-PCR agarose electrophoresis gel using
whole OB tissue as the template yields the
anticipated size product (452 bp) for the GLP-1R.
C, representative photomicrograph composites as in
(A) where a peptide binding assay was performed
to visualize (top) GLP-1 biotin conjugate binding
(GLP-1-biotin) competing with combined (bottom)
GLP-1-biotin plus GLP-1 unconjugated binding
(GLP-1 cold). D, representative photomicrograph
composite in which the section was co-labelled
with anti-GLP-1R (red, top), anti-IR kinase (green,
middle) with the merged image indicating MCs that
putatively exhibit both co-labelled proteins (yellow,
bottom). DAPI nuclear stain (blue) is cropped below.
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(Merchenthaler et al. 1999). RT-PCR strategies produced
a product of anticipated size for the receptor (452 bp) as
harvested fromwholeOB tissue (Fig. 2B). Because antisera
directed against G-protein coupled receptors, including
GLP1-R, can often create false positives, we further
confirmed GLP-1R protein expression, as well as the
location,with abinding essay.Here,GLP-1was conjugated
with biotin and detection employed streptavidin coupled
to a fluorescent dye (Fig. 2C). The binding assay confirmed
the receptor immunolabelling, demonstrating strong
binding of GLP-1-biotin in the MCL and GCL (Fig. 2C,
upper). The labelling in these layers was abolished when
the OB slice was alternatively incubated in the pre-
sence of excess unbiotinylated (cold) GLP-1 (Fig. 2C,
lower). It was previously demonstrated that IR kinase
was expressed in the MCL (Fadool et al. 2000; Lacroix
et al. 2008; Marks et al. 2009) and so we were interested in
determining whether it might be co-expressed with that of
the GLP-1R. Double-colour immunofluorescence images
of the OB lamina demonstrated that IR and GLP-1R
were co-expressed in an overlapping population of MCs
within the MCL (Fig. 2D). Finally, as parallel support for
the identity of the GLP-1R-expressing neurons across the
MCL, we performed S.C. injection of fluorescence-labelled
Ex4 in a transgenic line, Thy1-YFP, which expresses the
fluorescent protein inMCs (Feng et al. 2000), as previously
used to localize the distribution of the GLP-1 receptor in
the brain (Secher et al. 2014). Double-colour immuno-
fluorescence images demonstrated that all Thy1-YFP
positive MCs also reveal intracellular labelling for the
fluorescent Ex4 (Fig. 3, top). Consistent with previous
studies, GLP-1 analogues are internalized in neurons after
binding to the receptor (Roed et al. 2014; Secher et al.
2014; Roed et al. 2015). No fluorescence was observed in
MCs of mice deficient for GLP-1R (GLP-1R–/–) (Fig. 3,
bottom).
GLP-1 and Ex4 increase evoked AP firing frequency
in MCs
To determine any functional effect of GLP-1 on the
excitability of MCs, which represent the first relay of
the olfactory output to the central nervous system,
we used whole-cell, patch clamp recordings to determine
the effect of bath application of GLP-1 or its stable
analogue Ex4 on the evoked AP firing frequency. Evoked
APs were obtained by injecting supra-threshold currents
ranging from 25 to 100 pA. Modulation of AP firing
frequency was considered significant when the addition of
the peptide or analogue to the aCSF perfusion resulted in a
10% change compared to the basal frequency (aCSF only).
Bath applicationof 1μMGLP-1 resulted in a rapid increase
in AP firing frequency (369 ± 136%, P = 0.0009) in eight
of the 13 cells recorded (62%), which reverted when the
bath perfusion was washed with aCSF (Fig. 4A–C). The
effect was concentration-dependent in that the addition
of 100 nM GLP-1 to the aCSF for 5 min significantly
increasedMCfiring activity by 150± 31% (Friedman test,
P= 0.0239) in five of the 10 recorded cells (50%) (Fig. 4D).
Further spike analysis determined that the change in AP
firing frequency was driven by a reduction in the inter-
burst interval rather than a change in the ISI (Fig. 4E and
F). Although GLP-1 increased AP firing frequency, it did
not change the AP shape or the RMP of MCs. In response
to bath application of 1μMGLP-1, there was no change in
the 10–90% rise time (control = 0.73 ± 0.08 ms, peptide
Ex4-647
Ex4-647
Thy1-YFP
DAPI - GLP1R–/– Merge
EPL MCL GCL
EPL MCL GCL
20 μm
Merge
Figure 3. MCs internalize of fluorescent Ex4
Photomicrograph composites of OB sections from Thy1-YFP mice injected with fluorescent Ex4 (Ex4-647) showing
intracellular uptake of Ex4 in the MCs (top). GLP-1R−/− mice do not show uptake of Ex4-647 in the MCL (bottom).
DAPI, nuclear stain (blue); GLP-1R−/–, GLP-1R-null mice; Merge, merged image on the right using double-colour
fluorescence strategy to visualize the YFP (green) or DAPI (blue) with Ex4 (purple) overlay.
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Figure 4. GLP-1 increases MC firing frequency via shortening the spike interburst interval
A, line graph of AP firing frequency (event frequency) and associated raster plot for a representative MC in response
to bath application of 1 μM GLP-1 to the slice. Dashed line and black bar, application of GLP-1 proceeded by control
artificial cerebral spinal fluid (Control ACSF) to establish baseline firing frequency and followed by an aCSF wash
interval (Wash ACSF). B, enlarged resolution of AP firing pattern sampled at points a, b and c from (A). C, left: line
graph of the AP firing frequency for the individual MCs sampled as in (A) and (right) bar graph of the mean firing
frequency normalized to that of initial control ACSF condition. D, same as (C) but for 100 nM GLP-1. E, bar graphs
of the (left) ISI and (right) interburst interval for the AP activity recorded for the population of GLP-1 responsive
MCs in (C). F, same as (E) but for the AP activity recorded for the population of GLP-1 responsive MCs in (D).
D–F, different letters indicate significantly-different means; non-parametric repeated measure one-way analysis of
variance (ANOVA; Friedman test) followed by a Bonferoni post hoc comparison. P values are as indicated on the
graphs.
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0.76± 0.09ms; n= 8), width at half-maximumamplitude
(control = 1.64 ± 0.17 ms, peptide 1.63 ± 0.12 ms;
n = 8) or RMP (control = –51.4 ± 0.8 mV, peptide
–51.0 ± 1.6 mV; n = 8) (paired t test, all P 0.05).
Because GLP-1 is metabolized by dipeptidyl
peptidase-IV to yield a putatively inactive metabolite
[GLP-1 (9-36)-amide] (Sharma et al. 2013), resulting
in a plasma half-life of several minutes in vivo, high
affinity analogues (GLP-1 mimetics) have been developed
and therapeutically approved (Exenatide; Briones & Bajaj,
2006) that have indistinguishable pharmacology (Goke
et al. 1993; Thorens & Waeber, 1993) and the ability to
stimulate insulin secretion in the treatment of diabetes
(Eng et al. 1992; Donnelly, 2012). Therefore, we applied
1 μM Ex4, a stable analogue of GLP-1, to the slice using
a paradigm identical to that for GLP-1, which resulted in
a significant increase in AP firing frequency (172 ± 15%,
Friedman test, P = 0.0084) (Fig. 5A–C) in 64% of the
recorded cells (seven of 11 cells) (Fig. 5C). At 100 nM, no
significant change in the firing frequency was observed
(n = 6; data not shown). Similar to GLP-1, the observed
increase in firing frequency with 1 μM Ex4 was driven by
a reduction in interburst interval (Fig. 5D).
GLP-1 might increase not only the firing frequency,
but also the AP threshold to enhance MC excitability.
Although the stochastic firing pattern of MCs makes the
determinationof aprecise rheobase challenging (Balu et al.
2004), we were able to determine the current threshold
to elicit APs before and after GLP-1 perfusion (Fig. 6A).
GLP-1 significantly decreased the excitation threshold as
determined by the increased firing frequency observed
across the family of injected currents that demonstrated
a significant effect of peptide treatment (F1,5 = 20.94;
repeated-measures, two-way ANOVA, P< 0.0060; n= 6).
A Bonferroni’s post hoc test showed that the difference
lay with the lower current injection steps and not the
higher current injections that are sensitive to changes in
ISI (Fig. 6B).
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Figure 5. GLP-1 analogue, Ex4, increasesMC firing frequency via shortening the spike interburst interval
A and B, same experimental paradigm as in Fig. 4A and B but for bath application of 1 μM Ex4. C–D, same spike
analysis, statistical metric and notations as in Fig. 4C and E in the analysis of Ex4 as opposed to natural peptide
GLP-1.
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Effect of GLP-1 on the Kv1.3 potassium channel
Previous studies have demonstrated that GLP-1 or its
agonists can inhibit voltage-gated K+ currents such as
those driven by Kv channels of the Shaker subfamily in
pancreatic β-cells (MacDonald et al. 2003; Kim et al. 2012;
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Figure 6. GLP-1 decreases the excitation threshold for MC
firing
A, representative APs recorded in a representative MC held near
resting potential and injected with a family of 500 ms long currents
in 25 pA increments under control (Control) and following bath
application of 1 μM GLP-1 to the slice (GLP-1). B, line graph of the
mean AP firing frequency for a population of MCs (n = 6) recorded
as in (A) plotted against injected current. ∗∗Significantly different
means; repeated measure two-way ANOVA; Bonferoni’s post hoc
test, using hormone treatment as the factor. ∗∗P  0.01,
∗∗∗∗P  0.0001.
Kim et al. 2013) or nodose ganglion neurons (Gaisano
et al. 2010). Kv1.3 channels are known to transition to an
altered conducting state in response to changes in external
K+ (Jager et al. 1998). To determine whether the GLP-1
sensitive current was sensitive to external K+, we applied
a 400 ms voltage ramp from –120 to 40 mV to elicit an
outwardly rectifying current using two different external
K+ concentrations (Fig. 7A). This current was suppressed
by application of 1 μM GLP-1, where the difference
between control and GLP-1 conditions yielded the GLP-1
sensitive current (Fig. 7B). When using an external K+
concentration of 2.5 mMKCl, the activation threshold was
–56.3 ± 1.5 mV. When the neurons were bathed with an
external K+ concentration of 8.5 mM KCl, the activation
threshold changed to –46.7 ± 3.2 mV (t test, P < 0.05;
n = 5). These results indicate that the GLP-1 sensitive
current was sensitive to external K+, as is typical for Kv1.3
channels (Jager et al. 1998). Because our group previously
demonstrated that Kv1.3 drives 60–80% of the potassium
outward currents in MCs (Fadool & Levitan, 1998; Colley
et al. 2004; Fadool et al. 2004), we examined the AP firing
frequency following bath applicationof theAmericanbark
scorpion-derived peptide, MGTX, a selective blocker of
Kv1.3 (Knaus et al. 1995). As anticipated from parallel
investigations (Mast & Fadool, 2012), we observed an
increased AP firing frequency in MCs (Fig. 8A). Inter-
estingly, we found that this increase was correlated with
a reduction of the interburst intervals and no significant
change in the ISI (Fig. 8B), which is similar to the effect
observed after bath application of GLP-1 and Ex4 (Fig. 4E
and F and Fig. 5D).
To assess the effect ofGLP-1 onpotassiumconductance,
we performed whole-cell, voltage clamp recordings in
the presence of 1 nM TTX to isolate outward potassium
currents in MCs (Fig. 9). InWT animals, bath application
of 1 μM GLP-1 caused a significant suppression of
outward currents at depolarizing voltage steps beyond
+10mV(sevenof seven cells, repeated-measures, two-way
ANOVA, P < 0.0001) (Fig. 9A). I–V relationships were
plotted as normalized to capacitance (I/C) to standardize
any variance in MC size. No change was observed in
the I/Imax relationship, suggesting that the decrease in
conductance induced by GLP-1 did not change the
inherent voltage-dependence of the channels under-
lying the outward current. Despite the outward current
being driven predominantly by Kv1.3 (Fadool & Levitan,
1998), we further examined the role of this subfamily
member, explicitly repeating these experiments usingmice
deficient for Kv1.3 (Kv1.3−/−). Note that the magnitude
of voltage-dependent outward potassium currents is not
reduced in the absence of Kv1.3 (Control TTX traces in
Fig. 9A vs. B) as a result of the upregulation of expression
of Slack channels in the Kv1.3−/− mice (Lu et al. 2010).
No change in the I–V relationships were observed when
GLP-1 was added to the aCSF perfusion forMCs prepared
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from thesemice (eight of eight cells, P= 0.8089) (Fig. 9B).
In a parallel current clamp study (Fig. 10A, B), GLP-1
failed to significantly increase the AP firing frequency
in Kv1.3−/− animals in seven of the eight recorded cells
(Fig. 10C). These data strongly support a GLP-evoked
neuromodulation of MC excitability that is attributed in
part to an underlying Kv1.3 conductance. A plausible
model of how GLP-1 signalling may operate in the OB
is discussed below and is modelled in Fig. 11.
Discussion
Thepresent study is the first to report neuromodulation by
incretin hormones in the olfactory system. We have used
an advantageous transgenic marker to identify the PPG
neurons responsible for local processing in the OB. The
receptor for GLP-1 is localized to the first-order neurons,
the MCs, which are known to be modulated by a gamut
of other metabolically-important molecules linked to the
[K+]ext = 2.5 mM [K
+]ext = 8.5 mM
45I/C (pA/pF)
A
B
Voltage (mV) Voltage (mV)
Voltage (mV) Voltage (mV)
GLP-1 current (control - GLP-1)
a - Control
a-b
c-d
b - GLP-1
I/C (pA/pF)
I/C (pA/pF) I/C (pA/pF)
c - Control
d - GLP-1
40
35
30
25
20
15
5
20 40 600–5
–10
–20–40–60–80–100–120
20 40 600–20–40–60–80–100–120
10
10
12
8
6
4
–2
2
20 40 600–20–40–60–80–100–120
10
12
14
8
6
4
–2
2
40
45
50
35
30
25
20
15
5
20 40 600–5
–10
–20–40–60–80–100–120
10
Figure 7. The threshold for activation of
the GLP-1 sensitive current shifts with a
change in the equilibrium potential for K+
(EK) generated by altering the external
concentration for K+
A, representative I/C plotted relationship of
currents evoked using a 400 ms voltage ramp
from –120 to +40 mV before (a, Control, black
line) and after (b, GLP-1, grey line) bath
application of 1 μM GLP-1 to the slice under
conditions of 2.5 mM (left) vs. 8.5 mM (right)
external KCl concentration. B, the GLP-1
sensitive current is calculated by a subtraction
of a – b to yield an activation threshold of
–56.3 ± 1.5 mV using a 2.5 mM external K+
concentration (left) compared with the
right-shifted activation threshold of
–46.7 ± 3.2 mV using a 8.5 mM external K+
concentration (right).
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Figure 8. MGTX increases AP firing frequency in MCs by decreasing the interburst interval and not the
ISI
A, representative APs recorded in a representative MC under (a) baseline ASCF control bath conditions (Control),
(b) after 5 min of 1 nM MGTX and (c) after 15 min of 1 nM MGTX stimulation, reflecting the slow Kon reported
for this small peptide molecule that blocks the vestibule of the Kv1.3 channel. B, left: line graph of the mean
firing frequency over time for five sampled MCs normalized to initial AP firing rate before MGTX treatment (time
0 min). Right: same population of MCs plotted to examine AP mean ISI (closed symbol) and interburst interval
(open symbols) over time.
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Figure 9. The magnitude of MC
voltage-activated outward currents are
decreased following GLP-1 application in
WT mice but not for mice with a
Kv1.3-targeted deletion (Kv1.3–/–)
A, top: representative family of
voltage-activated currents elicited by
stepping the command voltage (Vc) in
10 mV increments (–100 to +40 mV) from a
holding voltage (Vh) of –80 mV using a
400 ms pulse duration (Pd) and a 45 s
interpulse interval. MC recordings were
acquired from WT mice. TTX was applied to
the bath to isolate outward potassium
conductances (Control, 1 nM TTX) before
(left traces) and after (right traces) bath
application of the peptide (+ 1 μM GLP-1).
Bottom left: plotted I/C relationship for five
MCs recorded as in (A). Solid symbols, before
(Control); open symbols, after GLP-1(GLP-1
1 μM) bath application. Significantly different
means; repeated measures two-way
ANOVA; Bonfernoni’s post hoc test,
∗P  0.05; ∗∗P  0.001. Right, same as left
I/C but normalized to that of the +40 mV
voltage step. B, as in (A), except MCs were
recorded from Kv1.3−/− mice (Kv1.3−/−).
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Figure 10. GLP-1 fails to modulate MC firing frequency in mice
with a Kv1.3-targed deletion (Kv1.3−/−)
A and B, same experimental paradigm as in Fig. 3A and B, although
MC were acquired in slices from Kv1.3−/− mice. C, same spike
analysis, statistical metric and notations as in Fig. 3C, as acquired
from Kv1.3−/− rather than WT mice.
regulation of the Kv1.3 potassium channel by current
suppression (Fadool et al. 2000; Marks et al. 2009; Fadool
et al. 2011; Tucker et al. 2013). TheGLP-1 sensitive current
is carried by a potassium conductance and modulation by
the peptide is lost in Kv1.3−/− mice or by pharmacological
blockade of Kv1.3 channels. GLP-1R activity in MCs is
thereforewell posed to alterMCexcitability bymodulating
downstream Kv1.3 function. Moreover, if centrally acting
GLP-1 peptide in the OB is inducible, either through food
availability or odour stimulation,GLP-1Ractivation could
trigger IR signalling, Kv1.3 phosphorylation or down-
stream glucose transporter translocation (Kovach et al.
2016) to alter energy utilization in the OB in addition
to modulation of the spike firing frequency of the major
output neurons.
Our combined immunocytochemical observations,
biochemical binding assays and molecular data strongly
support the presence of GLP-1 secreting dSACs and the
expression of the unique receptor, GLP-1R, on MCs.
The nucleus of the solitary tract, or nucleus tractus
solitarii, in the brainstem and the lumbar sacral spinal
cord (Llewellyn-Smith et al. 2015) are the only other
locations that have demonstrated cell bodies of GLP-1
producing neurons (Larsen et al. 1997; Tauchi et al. 2008;
Llewellyn-Smith et al. 2011; Alhadeff et al. 2012; Baggio &
Drucker, 2014). These studies report that GLP-1 neurons
send their axons broadly to different parts of the brain,
such as the paraventricular nucleus or arcuate nucleus of
the hypothalamus and the subfornical organ, whereas, in
contrast, GLP-1 neurons in the OB appear to limit their
projections. The GLP-1 secreting dSACs are consistent
with the Cajal type of dSACs (see below), which have
axons that reach into the MCL and EPL but do not
project to higher olfactory areas outside the OB (Price &
Powell, 1970; Eyre et al. 2008; Nagayama et al. 2014). Such
local processing through axodendritic pathways would
suggest a very local effect of GLP-1 on neuromodulation
of the olfactory output (Fig. 11, hypothesis 1), whereas the
dendrites might receive centrifugal projections. Whether
or not circulating GLP-1 can reach the central nervous
system remains highly controversial (Fig. 11, hypothesis 2)
because the circulatingGLP-1half-life is short (<2min) as
a result of rapid enzymatic inactivation byDDP-4 (Orskov
et al. 1996; Knauf et al. 2005; Donath & Burcelin, 2013).
Nevertheless, previous studies using radiolabelled insulin
suggest that the blood–brain barrier exhibits an eight-fold
higher permeability in the OB compared to other brain
regions (Banks et al. 1999), suggesting that circulating
GLP-1 could also play a role in olfactory modulation.
The nature of our PPG-YFP-positive signal in dSACs
does not corroborate the earlier detection of PPG
mRNA using in situ hybridization principally located
in periglomerular cells (Merchenthaler et al. 1999). The
PPG-YFP-positive signal is detected in dSACs and not
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superficial short axon cells surrounding the glomeruli
(juxtaglomerular neurons) (Kiyokage et al. 2010). The
dSACs are distinguished morphologically from granule
cells as a result of their intermediate size between
granule cells and MCs, and their cell bodies are contained
in the GCL or internal plexiform layer (Eyre et al. 2008).
With well-impregnated Golgi sections, Ramo´n y Cajal
(1911) and subsequent investigators distinguished seven
types of non-granule cells in the GCL, based upon soma
size, shape and location; orientation of dendrites; and
Centrifugal input
Metabolic control
Hormonal Control?
(CCK, Leptin)
Mitral Cell
dSAC
Blood Vessel
Leaky Blood Brain Barrier
GLM
MCL
GCL
1
2
3
4
GLP-1R
Kv1.3
GLP-1
GLP-1
InsR
?
Figure 11. Schematic of putative roles for GLP-1 in the OB
Glucagon-like peptide-1 (GLP-1) signalling pathways act to increase MC excitability, where several hypotheses
are proposed for its role in the OB. (1) GLP-1 could be used locally for dSAC-to-MC transmission or combined
neurotransmission/neuromodulation of MC activity; (2) MCs could sense GLP-1 as a metabolic signal of nutritional
state derived from peripheral release in the gut and brought to the OB through the circulation; (3) centrifugal
input could provide metabolic control of dSACs; or (4) hormones driven by peripheral metabolic signals may
govern dSAC peptidergic transmission. Regardless of the route of GLP-1 generation, its inducibility or regulation
of release, our data demonstrate that a downstream target is the Kv1.3 ion channel. The Kv1.3 channel (brown)
is predominantly expressed on MCs where it is known to be a substrate for IR kinase (blue) phosphorylation
on the N- and C-terminal aspects of the channel protein (Y111-113, Y137 and Y479) (Fadool & Levitan, 1998;
Fadool et al. 2000). Insulin-induced phosphorylation of Kv1.3 (inhibitory line) decreases Kv current magnitude by
decreasing the Propen of the channel rather than altering its unitary conductance (Fadool et al. 2000). GLP-1 is
known to stimulate insulin release in pancreatic β cells, a process that is glucose-dependent, although its activation
of IR kinase signalling in the brain is not known (arrow). Because Kv1.3 is part of a scaffold of protein–protein
interactions (Marks & Fadool, 2007), it is highly probable that IR kinase (Fadool et al. 2000; Fadool et al. 2011),
glucose signalling (Tucker et al. 2013) and GLP-1 signalling converge at the level of this channel, although whether
MCs homogeneously express all three metabolic factors that regulate their firing frequency is not fully understood.
Deletion of the Kv1.3 channel results in a thin body type and resistance to diet and genetic obesity (Fadool
et al. 2004; Tucker et al. 2008). Metabolic factors that decrease Kv1.3 ion channel activity increase the AP firing
frequency in MCs that is considered to provide odour quality coding of olfactory information. Such modulation
may in turn drive changes in odour-dependent food seeking behaviours in an environment where glucose, insulin
and GLP-1 do not remain static and can also be perturbed with metabolic dysfunction or obesity. GCL, granule
cell layer; MCL, mitral cell layer; GLM, glomerular layer.
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the presence or absence of dendritic spines, for which
members of a subdivision of interneuron types were
classified asdSACs (Ramo´nyCajal S., 1911; Price&Powell,
1970; Schneider & Macrides, 1978). A recent review by
Nagayama et al. (2014) provides an excellent summary of
the traditional morphological and synaptic distinctions
across the dSACs compared to recent reclassifications
using a different nomenclature (Eyre et al. 2008; Eyre
et al. 2009; Nagayama et al. 2014). The new classification
suggests that there are three subtypes of dSACs in
the inframitral layers: (1) the largest population with
column-like axonal arbors confined predominantly to
the external plexiform layer, or EPL-dSACs, and with
a soma location in the GCL (also referred to as Blanes
cells and Cajal cells); (2) a smaller population where the
soma is retained in the internal plexiform layer with a
horizontal axonal extension to the glomerular layer, or
GL-dSACs (also referred to as Horizontal cells and Golgi
cells); and (3) the smallest population with axonal arbors
constrained to the GCL only, or GCL-dSAC (also referred
to as Horizontal cells and Golgi cells). Our combined
morphological data (Fig. 1) and biophysical evidence
(Pressler et al. 2013; Fadool & Thiebaud, 2015) narrows
down the identification of the PPG-YFP-positive cells to
the EPL-dSAC classification and, in particular, to Cajal
cells. To our knowledge, this is the first report of a
neuromodulatory effect linked to Cajal cells. Boyd et al.
(2012) report that all dSACs are GABAergic and that Cajal
cells, in particular, participate in disynaptic relays (Boyd
et al. 2012). Understanding all of the contributions to
the synaptic network and the capacity for modulation is
fundamental to clarifyinghowCajal cellsmight participate
in sensory processing by controlling themainOB network
via inhibition of other interneurons. Our data do not
simplify the potential synaptic function of these dSACs.
The present study shows that Cajal cells contain not
only GABA, but also GLP-1, and could release both to
influence synaptic transmission within the OB. Moreover,
GLP-1 release from Cajal cells could be modulated by the
nutritional state to fine-tune communication between OB
laminae.We also cannot exclude the possibility that locally
released GLP-1 has a solely intrinsic or paracrine neuro-
modulatory effect within the defined OB circuit without
a metabolic-linked function. Whether GLP-1 levels in the
OB are modified in a nutritional state-dependent fashion
is completely unknown and deserves further study.
Our mapped distribution of GLP-1R in MCs (Fig. 2),
combined with our injection of fluorescently-conjugated
Ex4 that binds selectively to GLP-1R (Fig. 3), provides
parallel support for evoked GLP-1 release activating MCs
by binding to receptors on these cells. The biotinylation
results, along with the Ex4 binding assay, suggest that
the receptor distribution along MCs is homogeneous.
These findings are of interest given the recent studies
reporting a molecular and physiological diversity of MCs
that may not be a homogeneous population of neurons
with respect to voltage-gated ion channel expression
(Angelo et al. 2012; Padmanabhan & Urban, 2014).
Althoughour earlier immunocytochemical data (Fadool&
Levitan, 1998; Fadool et al. 2000) support a homogeneous
expression for Kv1.3 ion channel, GLP-1R activation may
have other downstream targets to mediate AP firing
frequency. We also cannot exclude the possibility that
there are preparation factors explaining why 50–64% of
MCs exhibited enhanced firing frequency in response to
GLP-1 or its analogue. Sectioning of the lateral dendritic
arbors during the slice preparation could result in less
than 100% of cells being responsive in our current
clamp recordings. Our electrophysiological findings show
that most (but not all) of the sampled MCs exhibit
a rapid and reversible increase in AP firing frequency
in response to GLP-1 or its analogue; therefore, they
do not unambiguously reveal whether all MCs have
identical neuromodulatory pathways. There are also a
diversity of adaptor proteins interacting with K+ channels
across the OB neurolamina (Marks & Fadool, 2007)
that could refine membrane excitability and olfactory
coding capacity. Finally, post-translationalmodificationof
delayed rectifiers or their auxillary β subunits has involved
GLP-1 evoked Ser/Thr phosphorylation and acetylation
(Kim et al. 2012). Because Kv1.3 has been well studied
and is known to be a substrate for Tyr phosphorylation
by several neuromodulators of MC AP firing frequency
(Fadool & Levitan, 1998; Fadool et al. 2000; Tucker &
Fadool, 2002; Colley et al. 2004; Fadool et al. 2011; Mast &
Fadool, 2012), it would be intriguing to explore whether
GLP-1 stimulation of the OB can phosphorylate Kv1.3 on
either Ser or Thr residues or use a cAMP independent
mechanism to phosphorylate Kv1.3 on Tyr residues linked
to MAPK activation (Egan et al. 2003).
As a post-prandial anorexigenic signal, GLP-1
modulation of MC excitability might be expected to be
correlated with a reduction in the sensitivity to food
odours. However, the change in GLP-1 concentration at
the level of the OB following a meal is unknown and
an increase in MC excitability does not necessitate a
gain in olfactory function. Indeed, MC intrinsic firing
is complex and variable, and may promote faster odour
discriminationwith increased inhibition. Fromour earlier
work (Fadool et al. 2000), we have demonstrated that
the concentration of another neuromodulatory molecule
in the OB (insulin) does not follow what is anticipated
frommeasured levels in the plasma. For example, in these
experiments, an overnight fast induced a plummeting of
plasma insulin, whereas that in the OB remained high.
As a post-prandial anorexigenic signal, we do not know
what explicitly activates PPG neurons, nor are we certain
that an elevation of GLP-1 in the periphery translates to
a linear change centrally at the OB. Second, inhibition of
MCs can be as critical to olfactory coding as excitation,
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and MC intrinsic firing properties can be modulated
differentially to several odours, being state- or sensory
experience-dependent (Kato et al. 2012). Some intriguing
work by Nunes & Kuner (2015) demonstrated that tuning
MC inhibition via disinhibition of granule cells resulted in
mice with faster odour discrimination without disruption
of olfactory learning. Therefore the inhibitory network in
the OB is working to adjust the speed of odour sensory
processing. Gschwend et al. (2015) report that neuro-
nal pattern separation is critical for odour discrimination
learning, where enhancing the inhibition ofMCs increases
odour-evoked pattern separation of activated glomeruli
and improves odour discrimination learning. Lastly, Li
et al. (2015) use a go no–go association task to reveal that
changes inMCfiring frequency encode information about
the rewarding nature of the odour, rather than the odour
identity. GLP-1 modulation of MC firing frequency may
therefore serve roles beyond that of a changed sensitivity
to food odours to include how (context and circuitry)MC
firing becomes changed as a critical variable influencing
odourdiscrimination (Gschwend et al.2015;Li et al.2015).
Neuromodulation by GLP-1 or its analogue has been
characterized in central neurons, such as hypothalamic
hypocretin/orexin neurons, or within vagal neural and
motor pathways (Acuna-Goycolea & van den Pol, 2004;
Wan et al. 2007a; Wan et al. 2007b; Gaisano et al. 2010).
Similar to our findings in the OB, GLP-1 can inhibit
voltage-gated potassium channels leading to an increase in
evoked Aps, such as observed in nodose ganglion neurons
(Gaisano et al. 2010). We have previously demonstrated,
both by pharmacological and genetic strategies, that Kv1.3
drives 60–80% of the outward potassium currents in the
MCs (Fadool & Levitan, 1998; Colley et al. 2004; Fadool
et al. 2004; Fadool et al. 2011); therefore, we investigated
the effect of GLP-1 stimulation in mice deficient for
this Kv family member. Similar to that found for insulin
(Fadool et al. 2011) and glucose (Tucker et al. 2013),
GLP-1 failed todecreaseoutward currents in voltage clamp
recordings and failed to modulate AP firing frequency
in current clamp experiments in which Kv1.3–/– mice
were substituted for WT mice. These data, combined
with the fact that a Kv1.3 pore blocker selectively altered
the spike train interburst but not ISI (Fig. 8), strongly
support the involvement of the Kv1.3 ion channel as
a downstream signalling component of GLP-1 neuro-
modulation of MCs (Fig. 11). Interestingly, although all
three metabolically-important molecules affect MC firing
in a Kv1.3-dependent manner, the mechanism shows a
difference in onset latency. Insulin elicits an increase in
AP firing frequency that is much slower to develop (in
the order of minutes) and difficult to wash out, which
may be the result of the Tyr-dependent phosphorylation
observed for Kv1.3 (Fadool & Levitan, 1998; Marks et al.
2009; Fadool et al. 2011). Modulation by glucose is rapid
and reversible (Tucker et al. 2013) and on the same
time course as that for GLP-1; however, glucose can be
excitatory or inhibitory, suggesting a heterogeneity in the
type of MC that exhibits glucose modulation or sensing.
Although we have not yet pursued strict co-localization
of Kv1.3 and GLP-1R, our current immunocytochemical
data suggest that IR kinase and GLP-1R are co-localized,
and our previously reported findings demonstrate that IR
kinase and Kv1.3 are not only co-localized, but also can
be co-immunoprecipitated in the presence of a variety
of adaptor proteins present in the OB (Marks & Fadool,
2007; Marks et al. 2009). There is certainly a glucose
dependence of GLP-1 evoked insulin release. The inter-
action ofGLP-1with glucose and insulin sensing pathways
has been well studied in pancreatic β-cells (Holst, 2007).
One could speculate an active interactionofGLP-1, insulin
and glucose in neurons such asMCs thatmight co-express
GLP-1R, IR kinase (Fadool et al. 2000) and glucose
transporters such as sodium-glucose transport protein-1
or insulin sensitive, glucose transporter 4 (Al Koborssy
et al. 2014), of which the latter is known to be
regulated by Kv1.3 (Xu et al. 2004). For conditions
during which insulin, glucose or GLP-1 peptide were
present, phosphorylation or other means of decreasing
Kv conductance would shift glucose transporter 4 trans-
location to the membrane (Kovach CP, Al Koborssy
D, Huang Z, Chelette B, Fadool JM, & Fadool DA,
unpublished) as a positive feedback for continued glucose
utilization inMCs to yield an ATP substrate for continued
activation of GLP-1R.
It is interesting that another class of chemosensory
receptors has been linked to the operation of GLP-1
signalling. The L cells of the gut have been found to
express α-gustducin, sweet taste receptors (T1R2/T1R3)
and PLCβ2 (Jang et al. 2007), and dietary sugar has
the capacity to increase sodium-dependent glucose trans-
porter isoform 1 in the presence of the taste trans-
duction machinery (Margolskee et al. 2007). Jang et al.
(2007) demonstrate that T1R3 and gustducin have a
role in glucose-mediated GLP-1 release and may serve
as a gut-derived lumenal glucose sensor. Reciprocally,
GLP-1 was found to be expressed in the tongue in two
distinct classes of taste cells and the receptor is found
on intragemmal afferent nerve fibres (Shin et al. 2008).
Gene-targeted deletion of the receptor reduced sweet taste
sensitivity in behaving mice as determined using brief
access gustatory tests. In light of these gut/chemosensory
parallels with the taste system, it is not unexpected that
the olfactory system could have the ability to regulate
glucose-dependent incretin release or the ability to sense
GLP-1 hormone.
In summary, our findings generate several new hypo-
theses (Fig. 11) concerning the role of GLP-1 in the
OB, each of which is important to consider within the
framework of future investigations: (1) GLP-1 could be
used locally for dSAC-to-MC transmission or combined
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neuromodulation of MC activity; (2) MCs could sense
GLP-1 as a metabolic signal of nutritional state derived
from peripheral release in the gut and brought to the
OB through the circulation; (3) centrifugal input could
provide metabolic control of dSACs; or (4) hormones
driven by peripheral metabolic signals may govern dSAC
peptidergic transmission. Activation of the dSAC inter-
neuron population to co-release GLP-1 peptide and a
neurotransmitter (hypothesis 1) could be explored using
select synaptic and GLP-1 receptor inhibitors. GLP-1 is
known to be an inducible peptide and changes in the
homeostatic state of the organism could be perceived
through circulating GLP-1 across a leaky blood–brain
barrier at the level of the OB (hypothesis 2). If peripheral
changes in GLP-1 are detected at the OB following a meal,
fasting or as a consequence of a metabolic disease state
(hypothesis 2–3), or if odour signalling pathways release
GLP-1 in the OB locally (hypothesis 1), GLP-1 sensitive
potassium currents are capable of enhancing the AP
firing frequency of the major output neurons or lowering
their threshold for excitability. Although we cannot yet
discriminate between these alternativemodels, the present
study definitively demonstrates that the GLP-1 signalling
pathway is present in the OB and can be a regulator of
neuronal activity. Taken together, the uncovered GLP-1
signalling and the highly-expressed glucose and insulin
metabolic factors in this region are especially interesting
in the context of the modulation of olfactory perception
and food intake. The reported discovery of this incretin
hormone in the OB challenges future investigations
to examine the olfactory system as a new potential
therapeutic target for controlling metabolic imbalance.
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